Figure 5
Figure 5. Notch blockade results in defective lymphangiogenesis during wound healing. (A) Wound gap size in control (PBS), αDll4, and αVEGF-A treated mice for 12 days after punch biopsy (n = 5; *αDll4 treatment, P < .05; **αVEGF-A treatment, P < .05). (B) Images of CD31 (green) and LYVE1 (red) costaining of the skin dermis in PBS- (control), αDll4-, or αVEGF-A–treated mice 12 days after a full thickness cutaneous wound. Dotted line represents the approximate skin/wound margin and arrow represents the edge of wound closure. Scale bar represents 500 μm.

Notch blockade results in defective lymphangiogenesis during wound healing. (A) Wound gap size in control (PBS), αDll4, and αVEGF-A treated mice for 12 days after punch biopsy (n = 5; *αDll4 treatment, P < .05; **αVEGF-A treatment, P < .05). (B) Images of CD31 (green) and LYVE1 (red) costaining of the skin dermis in PBS- (control), αDll4-, or αVEGF-A–treated mice 12 days after a full thickness cutaneous wound. Dotted line represents the approximate skin/wound margin and arrow represents the edge of wound closure. Scale bar represents 500 μm.

Close Modal

or Create an Account

Close Modal
Close Modal